Use of Newer Antiseizure Meds for Epilepsy Differ by Race, Ethnicity
(MedPage Today) -- Racial and ethnic minority groups are less likely to be taking newer-generation antiseizure medications (ASMs) for their epilepsy, an analysis of Medicaid data showed.
Compared with white patients, Black (adjusted OR 0.71, 95... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - January 11, 2023 Category: American Health Source Type: news
Use of Newer Antiseizure Meds for Epilepsy Differs by Race, Ethnicity
(MedPage Today) -- Racial and ethnic minority groups are less likely to be taking newer-generation antiseizure medications (ASMs) for their epilepsy, an analysis of Medicaid data showed.
Compared with white patients, Black (adjusted OR 0.71, 95... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - January 11, 2023 Category: American Health Source Type: news
Characteristics and Outcomes of Young Adult Patients with Severe Sepsis Admitted to Pediatric Intensive Care Units Versus Medical/Surgical Intensive Care Units.
Conclusions: Young adults with severe sepsis experience higher adjusted odds of mortality when treated in PICUs versus MICU/SICUs. However, there was no difference in length of stay. Variation in mortality is likely due to significant differences in the patient populations, including comorbidity status. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 11, 2023 Category: Consumer Health News Source Type: news
How much did pre-ACA Medicaid expansions matter?
This paper examines the impact of Medicaid expansions to parents and childless adults on adult mortality. Specifically, we evaluate the long-run effects of eight state Medicaid expansions from 1994 through 2005 on all-cause, healthcare-amenable, non-healthcare-amenable, and HIV-related mortality…#preacamedicaid #charlesjcourtemanche #antoniosmkoumpias #roman #jordanwjones #danielazapata #medicaid #nber (Source: Reuters: Health)
Source: Reuters: Health - January 10, 2023 Category: Consumer Health News Source Type: news
Why It ’s Hard to Get the New Alzheimer’s Drug Lecanemab
Alzheimer’s patients and their families welcomed the news on Jan. 6 that the U.S. Food and Drug Administration (FDA) approved a new treatment for Alzheimer’s disease. Lecanemab, marketed as Leqembi, is made by Eisai and Biogen for people in the early stages of the disease. The FDA granted lecanemab accelerated approval based on early phase testing results, and it’s now reviewing the companies’ completed data for consideration of traditional, full approval. It’s only the second drug approved to treat Alzheimer’s, not just address symptoms.
Doctors can now prescribe the medication, but man...
Source: TIME: Health - January 9, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Aging healthscienceclimate Source Type: news
CMS Awards 200 New Medicare-Funded Residency Slots to Hospitals Serving Underserved Communities
Announces that the Centers for Medicare and Medicaid Services (CMS) has awarded the first 200 of 1,000 Medicare-funded physician residency slots to 100 teaching hospitals across 30 states, the District of Columbia, and Puerto Rico. One hundred twenty-five of the residency slots are allocated for primary care, including obstetrics/gynecology, and 20 slots are allocated for psychiatry. (Source: News stories via the Rural Assistance Center)
Source: News stories via the Rural Assistance Center - January 9, 2023 Category: Rural Health Source Type: news
FDA Approves, Leqembi, New Treatment for Early Alzheimer ’s
The drug, Leqembi, may modestly slow cognitive decline in early stages of the disease but carries some safety risks. Still, data suggests it is more promising than the small number of other available treatments. (Source: NYT Health)
Source: NYT Health - January 6, 2023 Category: Consumer Health News Authors: Pam Belluck Tags: Drugs (Pharmaceuticals) Alzheimer ' s Disease Clinical Trials Medicare Placebos Labeling and Labels (Product) Aduhelm (Drug) Biogen Inc Centers for Medicare and Medicaid Services Eisai Co Ltd Food and Drug Administration New Engl Source Type: news
FDA Approves Lecanemab, a New Alzheimer ’s Drug
On Jan. 6, the U.S. Food and Drug Administration (FDA) approved a new drug to treat Alzheimer’s disease in its early stages.
Lecanemab, which will be available under the name Leqembi, can slow the cognitive decline associated with Alzheimer’s disease by 27%, according to data submitted to the FDA by the drug’s developers, Eisai and Biogen. It’s only the second medication to show any improvement in neurodegeneration, a key criterion in the FDA’s consideration for approval.
“For a long time, this is what we have been looking for,” says Dr. Sam Gandy, professor of neurology and psychi...
Source: TIME: Health - January 6, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Drugs healthscienceclimate Source Type: news
Patrick Allen reflects on his time in Oregon and what brought him to a cabinet position in New Mexico
The Oregon and New Mexico agencies are roughly the same size, with about 4,000 employees. But while Medicaid makes up a large part of OHA ’s focus and budget, New Mexico’s Department of Health does not oversee the program. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 6, 2023 Category: Pharmaceuticals Authors: Elizabeth Hayes Source Type: news
Oklahoma Bill Would Ban Gender-Affirming Care for People Under 26, Could Force Some to Detransition
As politicians in red states across the country pass one anti-trans bill after the next, they frequently claim that they’re doing so for the children. In Arkansas, Tennessee, Arizona, Alabama, and Florida, for example, where various bans on gender-affirming care for minors have been passed,…#redstates #tennessee #oklahoma #medicaid #arkansas #sb129 #aclu #erinreed #florida #millstoneact (Source: Reuters: Health)
Source: Reuters: Health - January 5, 2023 Category: Consumer Health News Source Type: news
Study finds hepatitis C cure saved Medicaid $15 billion
New research published in theAmerican Journal of Managed Care (AJMC) underscores the critical role that medicines play in improving health and reducing disease complications and other, often costly, medical care and services. The study finds that since curative direct-acting antiviral medications for hepatitis C were approved in 2013, even after factoring in the cost of treatment, Medicaid has saved an estimated $15 billion in avoided health care costs and nearly 285,000 Medicaid enrollees are estimated to have been cured. (Source: The Catalyst)
Source: The Catalyst - January 5, 2023 Category: Pharmaceuticals Authors: Lindsey Seidlitz Tags: Drug Cost Hepatitis C Medicaid Source Type: news
Ron DeSantis may be Republicans ’ best chance to prevent Donald Trump’s return
A the eighth day, God created Ron DeSantis. At least according to his campaign, that is. A few days before being re-elected as Florida’s governor on November 8th by a hefty 19-point margin, Mr DeSantis’s wife, Casey, tweeted out a campaign advertisement, in which Mr DeSantis appears as the…#proisrael #massachusetts #tampabaytimes #iowa #donaldtrump #florida #medicaid #cuban #newhampshire #muslim (Source: Reuters: Health)
Source: Reuters: Health - January 5, 2023 Category: Consumer Health News Source Type: news
Delta Dental Promotes Jennifer Morales to VP of Human Resources
Morales joined Delta Dental in late 2019 as the Director of Delta Dental Smiles, the company division administering state Medicaid dental benefits. (Source: Arkansas Business - Health Care)
Source: Arkansas Business - Health Care - January 4, 2023 Category: American Health Source Type: news
Missouri Judge Hands Planned Parenthood a Medicaid Win
The ruling rejects a lawmaker's effort to stop the women's health organization from receiving any public funding. (Source: Arkansas Business - Health Care)
Source: Arkansas Business - Health Care - January 4, 2023 Category: American Health Source Type: news
Millions Could Lose Medicaid by April as Pandemic Rules Ease
WEDNESDAY, Jan. 4, 2023 -- Millions of Americans are about to lose Medicaid coverage that they gained— and maintained hassle-free— through the pandemic.
The end-of-year spending bill that Congress passed will“unwind” a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 4, 2023 Category: General Medicine Source Type: news
